
This is a discussion on Ask here for fulltext research papers (Warning: WOT) within the Research Articles/User Guides forums, part of the Prohormone Forum category; Relative Potency of Various Steroids in an Anabolic-Androgenic Assay Using the Castrated Rat...
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
Author/Writer @
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
align="center">Iron Legion Rep
Author/Writer @
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
align="center">Iron Legion Rep
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
A tad unrelated but really need this:
I am looking for chapter 3 by O’Donovan. Genetic toxicity testing to qualify alerting impurities.
In “Genotoxic Impurities: Strategies for Identification and Control”. Edited by A. Teasdale, John Wiley & Sons, Inc, Hoboken NJ, pp 67-96 (2010).
I usually don't have too much trouble, even with obscure titles, but this one has eluded me. Hopefully someone can help, google scholar has a 'preview' however the pages it leaves out are the ones I need most. Thanks in advance if anyone can find it.
Cynical realism is the intelligent man's best excuse for doing nothing in an intolerable situation. -Aldous Huxley
Anyone get this for me?
Curr Vasc Pharmacol. 2011 Jul 1;9(4):385-400.
Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation.
Florentin M, Liberopoulos EN, Kei A, Mikhailidis DP, Elisaf MS.
Source
Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Campus, University College London Medical School, University College London (UCL), UK.
Abstract
AIMS:
Treatment with statins has significantly reduced cardiovascular morbidity and mortality, an effect attributed to both the low-density lipoprotein cholesterol (LDL-C) lowering capacity and the pleiotropic actions of these drugs. However, residual risk remains even after intense LDL-C lowering. Therefore, additional treatment with lipid-lowering drugs which improve other lipid parameters and have favourable non-lipid effects may be of clinical value. The aim of the present article is to review the actions of nicotinic acid and comment on the limitations and possible benefits of this drug in clinical practice.
METHODS:
Relevant articles were identified through a Pubmed search up to July 2010.
RESULTS:
Nicotinic acid (niacin) improves the lipid profile and has been associated with reduction in morbidity and mortality from cardiovascular disease. This favourable outcome may be due to several beneficial actions of this drug, such as antithrombotic, anti-inflammatory and antioxidant. However, its use has been limited due to side effects, especially flushing. A novel formulation with a prostaglandin D2 receptor antagonist (laropiprant) appears to substantially decrease the frequency and intensity of flushing, without affecting the other properties of niacin. Some concerns regarding treatment with nicotinic acid include impaired glucose metabolism and elevations in uric acid and homocysteine levels.
CONCLUSION:
Nicotinic acid is a safe supplementary (to statins) lipid lowering agent which may also improve cardiovascular outcomes. Whether its combination with laropiprant will be proved equally effective and more favourable in terms of adverse effects remains to be established by large clinical trials.
PMID: 21314635 [PubMed - indexed for MEDLINE]
Advanced Muscle Science & ForeRunner LabsLearn - Apply - Grow
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
Repped for trying
Advanced Muscle Science & ForeRunner LabsLearn - Apply - Grow
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
Thank you all.
Guys you are doing a wonderful job...
While less than enthusiastic about nootropics, this one's pronounced CNS stimulating properties I find interesting.
http://www.totalflexblog.com/articles/phenylpiracetam/
Sent from my iPhone using Tapatalk
Author/Writer @
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
align="center">Iron Legion Rep
A few interesting stuff on designer pharmacology:
Detection and pharmacokinetics of tetrahydrogestrinone in horses
Tetrahydrogestrinone analysis and designer steroids revisited.
The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of 'designer' steroids in the equine
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
Author/Writer @
To view links or images in signatures your post count must be 10 or greater. You currently have 0 posts.
align="center">Iron Legion Rep
Bookmarks